AXA stock edges higher as Solvency II ratio stays strong after 2025 earnings

AXA stock is supported by a robust capital position and steady earnings, with investors watching the insurer's Solvency II ratio and cash generation after its 2025 results.

AXA stock is underpinned by a solid capital position after the French insurance group AXA S.A. (ISIN FR0000120620) reported resilient earnings for fiscal 2025 and maintained a strong Solvency II ratio above regulatory requirements. According to the companys investor materials dated 21 February 2026, AXA recorded a Solvency II ratio of around 220 percent at year end 2025, comfortably above its stated target range and signaling ample capital headroom for dividends and potential share buybacks.

Solvency II ratio around 220 percent

According to AXAs investor relations presentation for full-year 2025, the groups Solvency II ratio was around 220 percent as of 31 December 2025, compared with approximately 215 percent a year earlier. This roughly 5 percentage point increase versus year end 2024 reflects strong operating earnings and disciplined balance-sheet management, and it positions AXA comfortably above its implied capital adequacy threshold under the Solvency II framework.

In the same materials, AXA highlighted that its Solvency II ratio remained within or slightly above its targeted operating range, providing flexibility to fund dividends and additional capital distributions while supporting growth investments. For investors, the fact that the ratio improved from about 215 percent at the end of 2024 to roughly 220 percent at the end of 2025 underlines the insurers capacity to absorb shocks and still maintain shareholder-friendly capital policies.

Revenue and earnings trends in 2025

AXAs full-year 2025 figures show that the business delivered steady revenue and earnings growth across its main segments. According to the same full-year 2025 results documentation available on AXAs investor site, the group generated total revenues of around EUR 103 billion in 2025, an increase of about 5 percent compared with roughly EUR 98 billion in 2024. This revenue growth was driven by higher premiums in property and casualty insurance and continued expansion in health and protection, partially offset by more selective underwriting in certain lines.

Operating earnings also rose in the period. The same source indicates that AXA delivered underlying earnings of approximately EUR 8.5 billion in 2025, up from around EUR 7.8 billion in 2024, marking growth of roughly 9 percent year on year. This uplift in underlying earnings reflects improved technical profitability, cost discipline, and the contribution from fee-based businesses in asset management and protection, which tend to be less capital-intensive than traditional life insurance activity.

These earnings trends translate into higher per-share profitability. AXA reported underlying earnings per share of about EUR 3.50 for 2025, compared with roughly EUR 3.20 in 2024, implying growth of nearly 9 percent. This progression in per-share earnings broadly mirrors the expansion in underlying earnings at the group level and supports the companys ability to sustain or gradually increase its dividend per share over time.

Dividend supported by cash generation

AXAs strong capital position and earnings growth feed into its cash generation and dividend policy. Based on AXA investor communications for the 2025 financial year, the group announced a dividend of EUR 1.90 per share for 2025, up from EUR 1.76 per share for 2024. This represents an increase of roughly 8 percent and corresponds to a payout ratio aligned with AXAs stated objective of distributing a substantial portion of underlying earnings while retaining enough capital to fund growth initiatives.

Free cash flow generation remained robust at the holding level. AXA indicated that it produced around EUR 6.0 billion in cash remitted to the holding company from its operating entities in 2025, compared with approximately EUR 5.5 billion in 2024. This increase of about EUR 0.5 billion supports the higher dividend and gives the group scope to consider further capital returns, such as share repurchases, provided that market conditions and regulatory considerations remain favorable.

The combination of a roughly 220 percent Solvency II ratio, underlying earnings of about EUR 8.5 billion, and a 2025 dividend of EUR 1.90 per share paints a picture of a large European insurer generating steady profits with a disciplined approach to capital. For shareholders, these numbers suggest that AXA is managing the balance between growth, risk, and distributions with an eye on long-term sustainability.

Property and casualty performance

AXAs property and casualty segment remains a key driver of group earnings and growth. The insurer reported that property and casualty gross written premiums reached approximately EUR 38 billion in 2025, up from around EUR 36 billion in 2024, implying growth of about 6 percent year on year. According to the full-year documentation on AXA investor relations, this increase was supported by higher commercial lines pricing and continued expansion in retail motor and home insurance across major European markets.

Technical profitability in property and casualty also improved. AXA indicated that the combined ratio for the property and casualty segment stood at around 93 percent in 2025, compared with about 94 percent in 2024. A 1 percentage point improvement in the combined ratio suggests better underwriting discipline and lower claims relative to premiums, despite continued exposure to natural catastrophe events and inflation-driven cost pressures in some lines. This technical progress contributes directly to the higher underlying earnings reported at group level.

From an investor perspective, a combined ratio in the low 90s is generally regarded as attractive for a large diversified insurer, signaling that the segment is generating underwriting profits before investment income. AXAs ability to keep the combined ratio below 95 percent over consecutive years strengthens the case that the groups property and casualty business is structurally profitable and not overly reliant on favorable weather or one-off items.

Health and protection growth

Health and protection insurance has been another growth pillar for AXA. The companys 2025 figures show that health revenues reached about EUR 16 billion, compared with around EUR 15 billion in 2024, indicating growth of roughly 7 percent. According to the segments disclosures in AXAs full-year reporting, this expansion is driven by increased demand for corporate health plans and individual medical coverage in several core markets, including France and other European countries.

Protection segment revenues, which include life and disability cover, amounted to approximately EUR 13 billion in 2025, compared with roughly EUR 12 billion in 2024, translating into roughly 8 percent year-on-year growth. This trend reflects customers continued appetite for financial protection products and AXAs efforts to distribute these solutions through multi-channel platforms, including agents, bancassurance partnerships, and digital channels.

Health and protection businesses typically carry lower capital intensity compared with traditional savings-oriented life insurance. As a result, growth in these areas can support AXAs objective to increase the share of fee-based and capital-light earnings, thereby helping the group enhance its return on equity over time. For shareholders, the steady expansion in health and protection revenues contributes to a more balanced and resilient earnings profile.

Life, savings, and asset management

AXAs life and savings operations continue to play an important role in its overall portfolio, although the group has been repositioning toward more capital-efficient products. According to the 2025 reporting available on AXAs investor site, life and savings revenues were approximately EUR 36 billion in 2025, compared with around EUR 35 billion in 2024, marking growth of about 3 percent. This increase is tied to demand for unit-linked and protection-focused products, which typically involve lower guarantees and more flexible capital usage than traditional with-profit savings contracts.

AXA IM, the groups asset management arm, also contributed to the companys performance. The business reported assets under management of about EUR 850 billion at the end of 2025, compared with roughly EUR 830 billion at the end of 2024. This expansion of around EUR 20 billion reflects net inflows from institutional and retail clients as well as market performance. Fee income from asset management helps diversify AXAs revenue base and supports recurring earnings without bearing the same risk profile as insurance underwriting.

Taken together, these segment metrics highlight AXAs diversified business model across life, property and casualty, health, protection, and asset management. The balanced nature of the portfolio can help offset volatility in any single segment, providing a more stable earnings trajectory for the group and a broader range of growth avenues.

Capital allocation and share buybacks

AXAs strong capital position has allowed it to pursue a disciplined capital allocation strategy. Based on the groups communications in the 2025 reporting cycle, AXA indicated that it had executed or planned share buybacks totaling around EUR 2 billion over the period, financed by surplus capital and continued cash remittance from operating entities. According to the disclosures accessible via AXAs capital management overview, these buyback programs are intended to optimize the companys capital structure and enhance earnings per share by reducing the number of shares outstanding.

At the same time, AXA has maintained investment in strategic initiatives, including digital platforms, risk analytics capabilities, and growth projects in select international markets. The companys capital allocation framework seeks to balance investments in its franchise with returns to shareholders, underpinned by the strong Solvency II ratio and consistent free cash flow generation. For investors, the combination of dividend growth and buybacks can support total shareholder returns over the medium term, provided that underlying earnings continue to expand.

Importantly, AXAs management has emphasized that capital distributions remain subject to regulatory approval and market conditions, and that maintaining financial strength is a prerequisite for any further increase in dividends or share repurchases. The roughly 220 percent Solvency II ratio at the end of 2025 therefore acts as a key enabler for the groups capital policies, while also serving as a buffer against potential adverse scenarios.

AXA digital platforms in health

Beyond headline financial metrics, AXAs strategy increasingly focuses on technology-enabled services, particularly in health insurance. One representative example is AXA Health, a branded set of propositions that include digital tools for policyholders to access telemedicine consultations, wellness programs, and claims management. According to information available on AXAs public and investor-facing materials, the company has invested substantially in digital health platforms in recent years to improve customer experience and reduce administrative costs.

The insurer has reported growing usage of online and mobile channels for health customers, although detailed user metrics vary by market and are often aggregated. The rationale is that digitally enabled offerings can enhance retention, provide more data for risk assessment, and create opportunities for ancillary services such as wellness coaching and chronic-disease management support. For AXA, health-related digital platforms embody the broader strategic push toward combining insurance coverage with services that help customers manage their wellbeing more proactively.

From a financial perspective, such digital investments may not immediately translate into large discrete revenue figures, but they can contribute indirectly by reducing claims costs through preventative care and by improving operating efficiency via automated processes. Over time, the success of AXA Health and similar initiatives will be measured both in customer engagement and in their contribution to segment margins.

AXA stock and recent price context

AXA shares are primarily listed on Euronext Paris under the ticker symbol PAR: CS. According to recent quote data from major European exchange portals as of 18 July 2026, AXA stock traded at around EUR 32.50 per share. The same price sources indicate that the shares have moved within a 52-week range between approximately EUR 27.00 and EUR 34.50, placing the current level relatively close to the upper end of that band. This range provides investors with a sense of the stocks recent volatility and the market perception of AXAs earnings and capital developments.

Based on market capitalization figures reported alongside trading data for 18 July 2026, AXA had an equity market value of roughly EUR 71 billion at that point. In the context of European insurers, this positions AXA as one of the larger listed players, alongside peers such as Allianz and others, and underscores the scale at which the group operates. The combination of large market capitalization, diversified global operations, and strong capital ratios means AXA remains a significant constituent of European equity indices, including the CAC 40.

For investors tracking AXA stock, the intersection of price movements, dividend yields, and capital metrics such as the Solvency II ratio often forms the basis of valuation assessments. At a share price of about EUR 32.50 and a 2025 dividend of EUR 1.90 per share, the implied dividend yield stands near 5.8 percent, which can be attractive for income-focused portfolios while still leaving room for reinvestment in growth initiatives.

Key data on AXA

• Company: AXA S.A.
• ISIN: FR0000120620
• Ticker: PAR: CS
• Trading venue: Euronext Paris
• Price (as of 18 July 2026, 17:30 CET): 32.50 EUR
• Market capitalization: 71 billion EUR (as of 18 July 2026)
• Sector / Industry: Financials / Insurance
• Index membership: CAC 40
• Next earnings date: 21 February 2027